This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Shilpa Prabhakar: Innovator in Gene Therapy
Introduction
Shilpa Prabhakar is a notable inventor based in Braintree, MA (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of tuberous sclerosis complex (TSC). Her innovative work has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Shilpa Prabhakar holds a patent for her invention titled "Gene therapy for tuberous sclerosis." This invention provides compositions and methods for treating TSC. In particular, it includes condensed tuberins (cTuberins), cTuberin nucleic acids, and recombinant adeno-associated viruses (rAAVs) carrying a cTuberin nucleic acid for treating a patient with TSC. She has 1 patent to her name.
Career Highlights
Shilpa is currently associated with The General Hospital Corporation, where she continues her research and development in gene therapy. Her work is recognized for its potential impact on medical treatments and patient care.
Collaborations
Shilpa has collaborated with esteemed colleagues, including Xandra O Breakefield and Casey Maguire, to advance her research and innovations in the field.
Conclusion
Shilpa Prabhakar is a pioneering inventor whose work in gene therapy is paving the way for new treatments for tuberous sclerosis. Her contributions are invaluable to the medical community and hold promise for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile